Metabolomic pattern of childhood neuroblastoma obtained by 1H-high-resolution magic angle spinning (HRMAS) NMR spectroscopy

Pediatric Blood and Cancer

Volumn 56, Issue 1, 2011, Pages 24-34

  Imperiale, Alessio ^a,b   Elbayed, Karim ^c   Moussallieh, François Marie ^a,c   Neuville, Agnès ^a   Piotto, Martial ^c,d   Bellocq, Jean Pierre ^a   Lutz, Patrick ^a   Namer, Izzie Jacques ^a,b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Université de Strasbourg Faculté de Psychologie   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d Bruker Corporation   (United States)

Author keywords

Adrenal medulla; Childhood malignancy; HRMAS; Neuroblastoma; NMR; Spectroscopy

Indexed keywords

ACETIC ACID; ADRENALIN; ALCOHOL; ARGININE; ASCORBIC ACID; ASPARTIC ACID; CHOLINE; CREATINE; FATTY ACID; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; GLYCEROL; GLYCEROPHOSPHORYLCHOLINE; GLYCINE; INOSITOL; LACTIC ACID; LYSINE; METHIONINE; N ACETYLASPARTIC ACID; PHENYLALANINE; PHOSPHORYLCHOLINE; PROLINE; SERINE; SUCCINIC ACID; TAURINE; THREONINE; UNINDEXED DRUG; URACIL;

1H HIGH RESOLUTION MAGIC ANGLE SPINNING NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ADRENAL MEDULLA; ARTICLE; CANCER STAGING; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INFANT; MALE; METABOLOMICS; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TUMOR BIOPSY;

ADRENAL MEDULLA; BIOPSY; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; METABOLOMICS; NEOPLASM STAGING; NEUROBLASTOMA;

EID: 78649655136     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22668     Document Type: Article

References (35)

1. Spix C, Pastore G, Sankila R, et al. Neuroblastoma incidence and survival in European children (1978-1997): Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42: 2081-2091.
2. Miller RW, Young JL, Jr., Novakovic B. Childhood cancer. Cancer 1995; 75: 395-405.
3. Grovas A, Fremgen A, Rauck A, et al. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 1997; 80: 2321-2332.
4. Shimada H, Umehara S, Monobe Y, et al. International Neuroblastoma Pathology Classification for prognostic evaluation of patients with peripheral neuroblastic tumors: A report from the Children's Cancer Group. Cancer 2001; 92: 2451-2461.
5. Goto S, Umehara S, Gerbing RB, et al. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: A report from the Children's Cancer Group. Cancer 2001; 92: 2699-2708.
6. Cotteril SJ, Pearson ADJ, Pritchard J, et al. Clinical prognostic factors in 1277 patients with neuroblastoma: Results of The European Neuroblastoma Study Group 'Survey' 1982-1992. Eur J Cancer 2000; 36: 901-908.
7. Adams GA, Shochat SJ, Smith EI, et al. Thoracic neuroblastoma: A Pediatric Oncology Group study. J Pediatr Surg 1993; 28: 372-377.
8. Hiorns MP, Owens CM. Radiology of neuroblastoma in children. Eur Radiol 2001; 11: 2071-2081.
9. Goo HW. Whole-body MRI of neuroblastoma. Eur J Radiol 2009; 23 [Epub ahead of print].
10. Kushner BH. Neuroblastoma: A disease requiring a multitude of imaging studies. J Nucl Med 2004; 45: 1172-1188.
11. 18Ffluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 therapy for relapsed neuroblastoma. J Clin Oncol 2009; 27: 5343-5349.
12. Lindskog M, Kogner P, Ponthan F, et al. Noninvasive estimation of tumor viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS). Br J Cancer 2003; 88: 478-485.
13. Vaidya SJ, Payne GS, Leach MO, et al. Potential role of magnetic resonance spectroscopy in assessment of tumor response in childhood cancer. Eur J Cancer 2003; 39: 728-735.
14. Lindskog M, Spenger C, Jarvet J, et al. Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma. J Natl Cancer Inst 2004; 96: 1457-1466.
15. Lindskog M, Spenger C, Klason T, et al. Proton magnetic resonance spectroscopy in neuroblastoma: Current status, prospects and limitations. Cancer Lett 2005; 228: 247-255.
16. Maris JM, Evans AE, McLaughlin AC, et al. 31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ. N Engl J Med 1985; 312: 1500-1505.
17. Naruse S, Hirakawa K, Horikawa Y, et al. Measurements of in vivo 31P nuclear magnetic resonance spectra in neuroectodermal tumors for the evaluation of the effects of chemotherapy. Cancer Res 1985; 45: 2429-2433.
18. Nicholson JK, Wilson ID. Understanding 'global' systems biology: Metabonomics and the continuum of metabolism. Nature Rev Drug Discov 2003; 2: 668-676.
19. Griffin JL, Shockor JP. Metabolic profiles of cancer cells. Nat Rev Cancer 2004; 4: 551-561.
20. Peet AC, McConville C, Wilson M, et al. 1H MRS identifies specific metabolite profiles associated with MYCN-amplified and non-amplified tumour subtypes of neuroblastoma cell lines. NMR Biomed 2007; 20: 692-700.
21. Wilson M, Davies NP, Brundler MA, et al. High resolution magic angle spinning 1H NMR of childhood brain and nervous system tumours. Mol Cancer 2009; 8: 6.
22. Shimada H, Ambros IM, Dehner LP, et al. Terminology and morphologic criteria of Neuroblastic tumors: Recommendations by the International Neuroblastoma Pathology Committee. Cancer 1999; 86: 349-363.
23. Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada System). Cancer 1999; 86: 364-372.
24. Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group. J Clin Oncol 1991; 9: 581-591.
25. Piotto M, Moussallieh FM, Dillmann B, et al. Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy. Metabolomics 2009; 5: 292-301.
26. Elbayed K, Dillmann B, Raya J, et al. Field modulation effects induced by sample spinning: Application to high-resolution magic angle spinning NMR. J Magn Reson 2005; 174: 2-26.
27. Piotto M, Bourdonneau M, Furrer J, et al. Destruction of magnetization during TOCSY experiments performed under magic angle spinning: Effect of radial B1 inhomogeneities. J Magn Reson 2001; 149: 114-118.
28. Shaka AJ, Lee CJ, Pines A. Iterative schemes for bilinear operators; application to spin decoupling. J Magn Reson 1988; 77: 274-293.
29. Davis AL, Keeler J, Laue ED, et al. Experiments for recording pure absorption heteronuclear correlation spectra using pulsed field gradients. J Magn Reson 1992; 98: 207-216.
30. Martinez-Bisbal MC, Marti-Bonmati L, Piquer J, et al. 1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas. NMR Biomed 2004; 17: 191-205.
31. Wishart DS, Tzur D, Knox C, et al. HMDB: Human metabolome database. Nucleic Acids Res 2007; 35: D521-D526 (Database issue).
32. Florian CL, Preece NE, Bhakoo KK, et al. Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours. NMR Biomed 1995; 8: 253-264.
33. Biedler JL, Roffler-Tarlov S, Schachner M, et al. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 1978; 38: 3751-3757.
34. Roberts SS, Mori M, Pattee P, et al. GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma. J Clin Oncol 2004; 22: 4127-4134.
35. Wharton BA, Morley R, Isaacs EB, et al. Low plasma taurine and later neurodevelopment. Arch Dis Child Fetal Neonatal Ed 2004; 89: F497-F498.